TrialAIDS and behavior2021

START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial.

Glenn J Wagner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.